David Roman
Stock Analyst
(n/a)
# 4,642
Out of 4,650 analysts
18
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIVN LivaNova | Initiates: Buy | $65 | $53.16 | +22.27% | 1 | Oct 4, 2024 | |
| IRTC iRhythm Technologies | Initiates: Neutral | $78 | $76.30 | +2.23% | 1 | Oct 4, 2024 | |
| TNDM Tandem Diabetes Care | Initiates: Neutral | $46 | $32.75 | +40.46% | 1 | Oct 4, 2024 | |
| SOLV Solventum | Maintains: Sell | $48 → $54 | $73.36 | -26.39% | 3 | Aug 12, 2024 | |
| BAX Baxter International | Maintains: Neutral | $36 → $40 | $36.01 | +11.08% | 2 | Aug 8, 2024 | |
| EW Edwards Lifesciences | Maintains: Buy | $107 → $91 | $68.52 | +32.81% | 2 | Jul 26, 2024 | |
| BSX Boston Scientific | Initiates: Buy | $90 | $84.76 | +6.18% | 1 | May 30, 2024 | |
| SYK Stryker | Initiates: Neutral | $372 | $356.01 | +4.49% | 1 | May 30, 2024 | |
| ISRG Intuitive Surgical | Initiates: Buy | $500 | $510.88 | -2.13% | 1 | May 30, 2024 | |
| ABT Abbott Laboratories | Initiates: Buy | $121 | $114.07 | +6.08% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $274 | $238.91 | +14.69% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $129 | $103.60 | +24.52% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sell | $83 | $90.60 | -8.39% | 1 | May 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $87 | $85.93 | +1.25% | 1 | May 30, 2024 |
LivaNova
Oct 4, 2024
Initiates: Buy
Price Target: $65
Current: $53.16
Upside: +22.27%
iRhythm Technologies
Oct 4, 2024
Initiates: Neutral
Price Target: $78
Current: $76.30
Upside: +2.23%
Tandem Diabetes Care
Oct 4, 2024
Initiates: Neutral
Price Target: $46
Current: $32.75
Upside: +40.46%
Solventum
Aug 12, 2024
Maintains: Sell
Price Target: $48 → $54
Current: $73.36
Upside: -26.39%
Baxter International
Aug 8, 2024
Maintains: Neutral
Price Target: $36 → $40
Current: $36.01
Upside: +11.08%
Edwards Lifesciences
Jul 26, 2024
Maintains: Buy
Price Target: $107 → $91
Current: $68.52
Upside: +32.81%
Boston Scientific
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $84.76
Upside: +6.18%
Stryker
May 30, 2024
Initiates: Neutral
Price Target: $372
Current: $356.01
Upside: +4.49%
Intuitive Surgical
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $510.88
Upside: -2.13%
Abbott Laboratories
May 30, 2024
Initiates: Buy
Price Target: $121
Current: $114.07
Upside: +6.08%
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $238.91
Upside: +14.69%
May 30, 2024
Initiates: Neutral
Price Target: $129
Current: $103.60
Upside: +24.52%
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $90.60
Upside: -8.39%
May 30, 2024
Initiates: Neutral
Price Target: $87
Current: $85.93
Upside: +1.25%